TABLE 3 from Phase Ib/II Study of a Liposomal Formulation of Eribulin (E7389-LF) plus Nivolumab in Patients with Advanced Solid Tumors: Results from Phase Ib
收藏数据链接：
官方服务：
资源简介：
Summary of tumor responses (per Investigator Review by RECIST v1.1)
创建时间：
2023-07-10
